Tengjun Biotechnology Corp. Depreciation
Tengjun Biotechnology Corp. reported Depreciation of -$291.58 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-08-15
- Tengjun Biotechnology Corp. depreciation for the quarter ending 2023-06-30 was -$336.79K, a 521.88% decline year-over-year.
- Tengjun Biotechnology Corp. depreciation for the quarter ending 2023-03-31 was $45.21K, a 46.25% decline year-over-year.
- Tengjun Biotechnology Corp. depreciation for the quarter ending 2022-12-31 was $71.14K, a 14.07% decline year-over-year.
- Tengjun Biotechnology Corp. depreciation for the quarter ending 2022-09-30 was $73.81K, a 8.10% decline year-over-year.
- Tengjun Biotechnology Corp. depreciation for fiscal 2022 was $308.89K, a 3.00% decline from fiscal 2021.
- Tengjun Biotechnology Corp. depreciation for fiscal 2021 was $318.44K, a 16.60% increase from fiscal 2020.
- Tengjun Biotechnology Corp. depreciation for fiscal 2020 was $273.11K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$336.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-15 | -$291.58K 10-Q · filed 2023-08-15 | -$220.44K derived: sum of 3 quarters · filed 2023-08-15 | -$146.63K derived: sum of 4 quarters · filed 2023-08-15 |
| 2023-03-31 | $45.21K 10-Q · filed 2023-05-15 | $116.35K derived: sum of 2 quarters · filed 2023-05-15 | $190.16K derived: sum of 3 quarters · filed 2023-05-15 | $269.99K derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-12-31 | $71.14K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $144.94K derived: sum of 2 quarters · filed 2023-04-17 | $224.78K derived: sum of 3 quarters · filed 2023-08-15 | $308.89K 10-K · filed 2023-04-17 |
| 2022-09-30 | $73.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $153.64K derived: sum of 2 quarters · filed 2023-08-15 | $237.75K 10-Q · filed 2022-11-14 | $320.53K derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-06-30 | $79.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-15 | $163.94K 10-Q · filed 2023-08-15 | $246.72K derived: sum of 3 quarters · filed 2023-08-15 | $327.04K derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-03-31 | $84.11K 10-Q · filed 2023-05-15 | $166.89K derived: sum of 2 quarters · filed 2023-05-15 | $247.21K derived: sum of 3 quarters · filed 2023-05-15 | $325.42K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $82.78K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $163.10K derived: sum of 2 quarters · filed 2023-04-17 | $241.31K derived: sum of 3 quarters · filed 2023-04-17 | $318.44K 10-K · filed 2023-04-17 |
| 2021-09-30 | $80.32K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-14 | $158.53K derived: sum of 2 quarters · filed 2022-11-14 | $235.67K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $78.21K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-09-16 | $155.35K 10-Q/A · filed 2022-09-16 | ||
| 2021-03-31 | $77.14K 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $273.11K 10-K · filed 2022-03-31 |